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Hormones may play a role in the pathophysiology of vernal keratoconjunctivitis (VKC). An increased incidence of thyroid
autoantibodies was recently observed in VKC, although there were no data on thyroid function. Two hundred and eighty-eight
patients (202 males, 86 females; range 5.5 to 16.9 years) with VKC were evaluated and compared with 188 normal age- and sex-
matched subjects. In all subjects, serum concentrations of free T4, TSH, thyroperoxidase, thyroglobulin, and TSHr autoantibodies
were evaluated. In VKC, the family history of thyroid diseases showed no significant differences compared to the controls (9.4
versus 8.6%), whereas the family history of autoimmune diseases was significantly higher (13.2% versus 6.3%; 𝑃 < 0.05). Subclinical
hypothyroidismwas diagnosed in 6.6% (versus 1.6% of the controls;𝑃 < 0.05) and overt hypothyroidism in 0.7% (versus 0.0% of the
controls; 𝑃 = NS). Finally, 5.2% of patients were positive for thyroid autoantibodies, which were significantly higher with respect to
the controls (0.5%, 𝑃 < 0.05). In the patients positive for thyroid autoantibodies, 80% showed a sonography pattern that suggested
autoimmune thyroiditis.Thyroid function and autoimmunity abnormalities are frequently present in children with VKC. Children
with VKC should be screened for thyroid function and evaluated for thyroid autoimmunity.
1. Introduction
Vernal keratoconjunctivitis (VKC) is a severe inflammatory
disease that commonly manifests seasonally during child-
hood, whereas a perennial and persistent form of the disease
is less frequent [1].
The aetiology and immunopathogenesis of VKC remain
unclear [1]; despite the assumption that VKC is part of
the family of allergic diseases, a large proportion of the
patients diagnosed have no familial or personal history of
atopic disease and can have negative results on the standard
allergic diagnostic tests. However, antiallergic therapy is often
unsuccessful [1]. In VKC patients, the male-female ratio has
been reported to range from 4 : 1 to 2 : 1 [2].
All types of VKC are characterised by intense itch-
ing, tearing, mucous secretions, and severe photophobia.
Cytological, biohumoral, immunohistological, andmolecular
biological studies indicate that VKC is a Th2 lymphocyte-
mediated disease. Mast cells and eosinophils, as well as their
mediators, play major roles in the clinical manifestation of
VKC. In addition to typical Th2-derived cytokines (IL-4, IL-
5, and IL-13), other cytokines, such as chemokines, growth
factors, and enzymes, are overexpressed in the conjunctiva of
VKC patients [2, 3].
Because of the notable difference between genders and
the resolution of this disease after puberty, it has been sug-
gested that hormonal factors play a role in the development of
VKC by influencing the immune deviation and the response
to environmental factors, in addition to genetic, unknown,
and predisposing conditions [2].
Sex hormones may also play a relevant role in the patho-
physiology of allergic diseases by reciprocal interactions
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between the immune and endocrine systems. Oestrogen and
progesterone have been shown to be active players in the
ocular immune system. In an immunohistochemical study
of patients with VKC, oestrogen and progesterone receptors
were shown to be overexpressed in eosinophils and other
inflammatory cells on the conjunctiva [2]. These hormones
may bind to conjunctival receptors and exert a proinflam-
matory effect through the recruitment of eosinophils to the
conjunctival tissue [4].
Sex hormone-related diseases, such as gynaecomastia,
polycystic ovary syndrome, mammary fibroadenoma, and
adiposogenital dystrophy, or autoimmune diseases have been
reported in 2% of patients suffering from VKC [5]. However,
recent data reported that VKC patients may have a higher
frequency of a family history of autoimmune disorders [6],
thyroid autoantibodies [7], and antinuclear antibodies (ANA)
[6, 8]. Thus, the purpose of this study was to evaluate the
prevalence of abnormalities of thyroid function and autoim-
munity in a cohort of patients with VKC.
2. Subjects and Methods
Two hundred and eighty-eight consecutive patients (202
males, 86 females; median age 9.7, range 5.5 to 16.9 years)
with VKC were recruited from July 2005 to February 2012
at the Paediatric Allergology Unit at Anna Meyer Children’s
University Hospital in Florence, Italy.
Ethical approval was obtained from the Ethics Committee
at Anna Meyer Children’s University Hospital. After an
explanation of the nature of the study, written informed
consent was obtained from the parents.
2.1. Case Definition and Study Protocol. A diagnosis of VKC
was established according to the presence of giant tarsal
papillae and/or limbal papillae relapsing in the spring and
summer [9]. The symptoms were associated with a mild
to severe cobblestone-like appearance in the upper tarsal
conjunctiva, mucous discharge, epithelial keratopathy, and
at least two eosinophils per optic field (100x, oil immersion
lens) in the conjunctival scraping. Finally, each patient was
evaluated to distinguish between the limbal, tarsal, andmixed
forms, as well as between seasonal and perennial symptoms
(Table 1 and Figure 1).
The skin prick test, specific IgE serumconcentrations, and
peripheral blood eosinophil count were also performed [1].
Parents were asked when their children first manifested
symptoms of VKC. The possible prolonged administra-
tion of either systemic or topical drugs, including antihis-
tamines, corticosteroids, cyclosporine, and nonsteroidal anti-
inflammatory drugs, was also investigated.
In all of the subjects, the serum concentrations of
free-T
3
(FT
3
), free-T
4
(FT
4
), thyroid stimulating hormone
(TSH), thyroperoxidase autoantibodies (TPOA), thyroglobu-
lin autoantibodies (TgA), and TSH-receptor (TSHr) autoan-
tibodies, as well as ultrasonographic data when appropriate,
were evaluated. Additionally, continuous data such as height,
pubertal staging, weight, and body mass index (BMI) were
collected; the last parameter was considered as the standard
deviation score (SDS).
Finally, all of the patients and control subjects and/or
their parents were interviewed about their family history
of autoimmune diseases up to their second-degree rela-
tives. The following autoimmune diseases were considered:
autoimmune thyroid diseases, rheumatoid arthritis and other
rheumatological disorders, coeliac disease, type 1 diabetes
mellitus, vitiligo, alopecia, multiple sclerosis, and inflamma-
tory bowel disease [10].
Exclusion criteria from the study for VKC patients and
controls were the presence of a history of an already diag-
nosed thyroid or autoimmune disease.
2.2. Thyroid Function. FT
4
, FT
3
, and TSH serum levels
were measured using immunometric assays (Immulite 2000,
Third Generation, DPC Diagnostic Products Corporation,
Los Angeles, CA, USA). Interrun coefficients of variation
were <8.5% for TSH, <7.5% for FT
4
, and <9.1% for FT
3
.
The normal ranges were adapted by Stagi et al. as previously
reported [11].
Subclinical hypothyroidism was defined as a TSH level
above the upper reference limit for age in conjunction
with normal serum thyroid hormone levels. Overt hypothy-
roidismwas defined as persistently increased TSH levels with
decreased serum thyroid hormone levels.
2.3. Thyroid Antibodies. Thyroid autoimmunity was evalu-
ated using fluorescence enzymatic immunoassays of TgA and
TPOA antibodies; positive TgA values were considered to be
≥50 IU/mL and TPOA ≥ 100 IU/mL [10]. TSHr autoantibod-
ies were measured with THBIA (DiaSorin Spa, Vercelli, Italy)
using a two-step radioreceptor assay; TSHr was considered to
be positive when values were >9 U/L.
2.4. Thyroid Sonography. The thyroid volume and morphol-
ogy, when appropriate, were investigated using an Advanced
Technology Laboratories (ATL) high-definition imaging
(HDI) 5000 ultrasound scanner (ATL Ultrasound, Bothell,
WA, USA) in combination with a 5–12MHz linear trans-
ducer. Thyroid sonography was performed by experienced
radiologists who were unaware of the diagnosis, thyroid
hormones, or antibody levels of the subjects.
2.5. Control Group. To compare thyroid function and auto-
immunity, a group of 188 (median age 9.5, range 1.8 to 14.6
years, 𝑃 = NS) normal age- and sex-matched subjects with
no history of atopic ocular/systemic diseases and who have
been admitted to the hospital for minor surgery (e.g., adeno-
tonsillectomy, phimosis, dermoid cyst, and herniotomy)were
selected from the same geographical area. Studies regarding
a portion of this group have been previously reported [10, 11].
3. Statistical Analysis
Statistical analyses were performed using SPSSX (SPSSX Inc.,
Chicago, IL, USA). The 𝜒2-test or Fisher’s exact test, when
appropriate, was used to compare differences between the
patients and control subjects. Bonferroni’s correction for
multiple comparisons was also applied in selected instances.
Summaries of the continuous variables are given as the
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Table 1: Demographic data, familial occurrence of autoimmune and thyroid diseases, and prevalence of thyroid dysfunction and
autoimmunity in vernal keratoconjunctivitis (VKC) patients and controls.
VKC Controls 𝑃
Subjects (𝑛) 288 188 —
Tarsal 23% — —
Mixed 16% — —
Limbal 61% — —
Males : females 202/86 133/55 NS
Median age (yr) 9.7 9.5 NS
Skin prick tests positivity (%)
Dermatophagoides 72% — —
Gramineae 56% — —
Cat fur 12% — —
Familial occurrence of autoimmune diseases 13.2% 6.3% <0.05
Familial occurrence of thyroid diseases 9.4% 8.6% NS
FT3 (pmol/L) 6.84 ± 0.66 6.51 ± 0.79 NS
FT4 (pmol/L) 15.52 ± 3.57 15.13 ± 4.31 NS
TSH (𝜇UI/mL) 5.42 ± 2.31 2.81 ± 1.24 <0.0001
Subclinical hypothyroidism 6.6% 1.6% <0.05
Overt hypothyroidism 0.7% 0.0% NS
Autoimmune thyroiditis 5.2% 0.5% <0.05
NS = not significant.
mean ± SD and the range. Statistical tests were two-tailed and
considered to be significant when 𝑃 < 0.05.
4. Results
The primary characteristics of thyroid function and autoim-
munity in our cohort of VKC patients and controls are
summarised in Table 1.
Associated allergic manifestations such as asthma,
eczema, or rhinitis were observed in 34.9% of the patients,
and a family history positive for allergic diseaseswas recorded
in 29.5% of the VKC patients. A positive skin prick test for
common allergens was observed in 52.1% of the patients, and
serum containing specific IgE was detected in 53.7% of the
patients.
Twenty-seven (9.4%) patients had a positive family his-
tory of thyroid disease (15 autoimmune thyroid diseases, 8
thyroid nodules, and 4 goitre), which was not significantly
different compared to the control group (8.6%; 𝑃 = NS).
However, 38 (13.2%) of the VKC cases had a positive family
history of autoimmune diseases, which was significantly
higher compared to the control subjects (12 subjects, 6.3%,
𝑃 < 0.05). Of these, 15 (5.2%) patients had a positive
family history of autoimmune thyroid diseases (versus 3.7%
of the control subjects, 𝑃 = NS): 12 (4.2%) for Hashimoto’s
thyroiditis and 3 (1.0%) for autoimmune hyperthyroidism.
Subclinical hypothyroidism was diagnosed in 19 patients
(6.6%) and overt hypothyroidism in 2 patients (0.7%). The
frequency of subclinical hypothyroidism was significantly
higher than the control group (3 patients, 1.6%, 𝑃 < 0.05),
whereas the frequency of overt hypothyroidism did not differ
from the control group (0 subjects, 𝑃 = NS).
The FT
3
levels were similar between the VKC patients
(6.84±0.66 pmol/L) and control subjects (6.51±0.79 pmol/L,
𝑃 = NS). The FT
4
levels were also similar between the
VKC patients and control subjects (15.52 ± 3.57 versus
15.13 ± 4.31 pmol/L, 𝑃 = NS). However, the TSH levels
were considerably higher in VKC patients compared to the
control group (5.42 ± 2.31 versus 2.81 ± 1.24 𝜇UI/mL, 𝑃 <
0.0001) (Figure 2); if patients with subclinical and overt
hypothyroidism were excluded, the TSH levels were not
significantly different compared to the control group (2.99 ±
0.97 versus 2.81 ± 1.24 𝜇UI/mL, 𝑃 = NS).
Fifteen (5.2%) patients were positive for thyroid autoan-
tibodies, and this percentage was significantly higher com-
pared to the control group (1 subject, 0.5%, 𝑃 < 0.05).
Two patients with overt hypothyroidism were a part of this
group. No patients were positive for TSHr autoantibodies.
In the patients who were positive for thyroid autoantibodies,
12/15 (80%) showed a heterogeneous echotexture and diffuse
hypoechogenicity on their thyroid sonography, whereas the
remaining 3 patients showed normal echostructure and
echogenicity (0.5%, 𝑃 < 0.05). These 3 patients were
determined to have subclinical hypothyroidism.
L-Thyroxine treatment became necessary for one patient
with autoimmune thyroiditis and overt hypothyroidism
because of the persistently increased TSH levels in this
patient, whereas another patient was continually followed
over time.
Upon evaluation of the different forms of VKC, we did
not find differences regarding a family history of autoimmune
diseases and thyroid diseases or of thyroid autoimmunity and
function.
4 International Journal of Endocrinology
(a) (b) (c)
Figure 1: Severe conjunctival redness in a male with vernal keratoconjunctivitis (a); “cobblestones” giant papillae on the upper tarsal
conjunctiva (b); Horner-Trantas dots (raised, white accumulations of eosinophils), associated with gelatinous thickened and opacification
of the limbus with copious amounts of mucoid discharge (c).
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Figure 2: Thyroid stimulating hormone (TSH) levels in VKC
patients compared to the control group. ∗∗∗𝑃 < 0.001.
5. Discussion
Our data show, to the best of our knowledge for the first time,
an increased prevalence of thyroid function abnormalities in
VKCpatients. However, our study confirms that patients with
VKC also present a higher prevalence of thyroid autoimmu-
nity, confirming the findings of Tesse et al. [7], who reported a
higher rate of positivity of thyroid autoantibodies in patients
with VKC compared to healthy subjects, despite the fact that
thyroid function in the VKC patients was not studied. The
same study also discovered that, in 181 VKC children, 22%
were positive for AbTG, 14.6% for AbTPO, and 15.8% for
ANA.
In evaluating thyroid function and thyroid sonography
in VKC, our study suggests that these patients may be
at a higher risk to develop autoimmune thyroiditis com-
pared to the general population. These data are particu-
larly important because a high percentage of VKC patients
with thyroid autoantibodies also showed a higher rate of
thyroid dysfunction, primarily manifesting as subclinical
hypothyroidism.We observed that 33.3% of our patients with
thyroid autoantibodies also presented with either subclinical
or overt hypothyroidism, which emphasises the importance
of evaluating thyroid function in VKC patients.
Our study showed that VKC patients have a significantly
higher prevalence of a family history of autoimmune diseases,
confirming the data of Zicari et al. [6] and Tesse et al. [7].
For example, Tesse et al. showed that 12.2% of VKC cases
had a positive family history of psoriasis; 5.2% of the patient
group was positive for thyroiditis, which suggests the role of
common components associated with these immune-based
diseases in the development of thyroid autoimmunity [7].
VKC has been associated with sex hormone-related
diseases. Disorders such as gynaecomastia, polycystic ovary
syndrome,mammary fibroadenoma, and adiposogenital dys-
trophy, as well as autoimmune diseases, have been reported
by 2% of patients diagnosed with VKC [5].
It is also interesting to note that an excessive growth of
eyelashes has been reported in patients with VKC [12], and
this condition is associated with hypothyroidism in some
genetic diseases [13].
The cause of the observed higher frequency of autoim-
mune thyroiditis and thyroid dysfunction in VKC patients is
unclear. It is also unknown if VKC is associated with other
autoimmune disorders. Further studies should be conducted
to elucidate the possible mechanism behind this relationship.
The significant increase in the frequency of a family history
of autoimmune diseases disclosed by VKC patients may also
suggest a role of common components of the immune system
in the pathogenesis of these disorders.
Autoimmune thyroid diseases (AITD), which affect
approximately 5% of the adult population (with a larger
incidence in women), result from the disruption of self-
tolerance induced by environmental factors in genetically
susceptible individuals [14] and are characterised by lym-
phocytic infiltration of the thyroid, the generation of anti-
bodies against thyroid antigens, and thyroid dysfunction.
The clinical spectrum of autoimmune diseases encompasses
Hashimoto thyroiditis (the most common form), Graves’
disease, postpartum thyroiditis, drug induced thyroiditis,
thyroiditis within polyglandular autoimmune syndromes,
and atrophic thyroiditis [15].
Phenotypic expression of thyroid autoimmunity is depen-
dent on the pattern of the immune response that predomi-
nates at any given time. Abnormal interactions between thy-
rocytes and immunocompetent (e.g., macrophages, dendritic
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cells, and T-cells) and other immune cells generate autoim-
munity. However, Th2 immune responses also downregulate
theTh1 immune response [16]. Because these subpopulations
tend to function antagonistically toward one another, the
balance between Th1 and Th2 lymphocytes may determine
the outcome of autoimmune diseases [17].
Hashimoto thyroiditis is a typical T-cell-mediated auto-
immune disease and is characterised by formation of tertiary
lymphoid follicles within the thyroid (containing T-cells,
increased Th1, and B cells), with the destruction of thyroid
follicular cells generating hypofunction and the presence of
anti-TPO and/or anti-Tg antibodies in the serum.
However, in patients with VKC, the clear abundance of
Th2 cytokines, the upregulated expression of their receptors,
and the conspicuous paucity of T helper cell type 1 (Th1)
cytokines in the tears and serum confirm the crucial role of
these factors in the onset and perpetuation of the chronic
allergic inflammation observed in these patients [18]. The
immune, nervous, and endocrine systems appear to interact
with each other in the pathogenesis of VKC [19].
Although allergic diseases (Th2 disorders) and autoim-
mune diseases (Th1-mediated) are usually considered to
be diametrically opposed in the immune response, this
contention is now less evident because it has been found
that allergy-associated mechanisms can contribute to the
pathogenesis of autoimmune diseases, such as multiple scle-
rosis [20]. However, an association between the presence of
wheezing as a measure of asthma and the occurrence of type
I diabetes [21] as well as between an allergic constitution
(asthma, atopic eczema) and AITD [22] was observed. Fur-
thermore, there is a correlation between the elevated levels
of immunoglobulin E and a slower decrease in TSH-receptor
autoantibody levels, alongwith a lower chance of remission of
the disease after antithyroid drug treatment in patients with
Graves’ disease [23, 24]. Additionally, patients with a relapse
of Graves’ hyperthyroidism had a higher rate of allergic rhini-
tis attacks compared to patientswhowent into remission [25].
It is interesting to note that there is also an association
between another allergic disease (chronic urticaria) and
Hashimoto’s thyroiditis, as TPO and/or Tg autoantibodies
were foundmore frequently in patients with chronic urticaria
and angioedema compared to healthy controls [26].
6. Conclusions
Abnormalities of thyroid function and thyroid autoimmunity
are present in children with VKC. The possible relationship
between these disorders should be confirmed and further
studied. Children with VKC should also be screened for
thyroid function to evaluate possible thyroid autoimmunity
in the presence of hypothyroidism.
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